Proceedings of the 15th Annual UT-KBRIN Bioinformatics Summit 2016 by Eric C. Rouchka et al.
BMC Bioinformatics 2016, 17(Suppl 10):297
DOI 10.1186/s12859-016-1154-yMEETING ABSTRACTS Open AccessProceedings of the 15th Annual UT-KBRIN
Bioinformatics Summit 2016
Cadiz, KY, USA. 8-10 April 2016
Published: 19 August 2016I1
Proceedings of the Fifteenth Annual UT- KBRIN Bioinformatics
Summit 2016
Eric C. Rouchka1,2, Julia H. Chariker2,3 (julia.chariker@louisville.edu),
Benjamin J. Harrison2,4 (b.harrison@louisville.edu), Juw Won Park1,2
(juw.park@louisville.edu)
1Department of Computer Engineering and Computer Science,
University of Louisville, Duthie Center for Engineering, Louisville, KY
40292, USA; 2Kentucky Biomedical Research Infrastructure (KBRIN)
Bioinformatics Core, 522 East Gray Street, Louisville, KY 40292, USA;
3Department of Psychological and Brain Sciences, University of Louisville,
Louisville, KY 40292, USA; 4Department of Anatomical Sciences and
Neurobiology, University of Louisville, Louisville, KY 40292, USA
Correspondence: Eric C. Rouchka (eric.rouchka@louisville.edu) –
Kentucky Biomedical Research Infrastructure (KBRIN) Bioinformatics Core,
522 East Gray Street, Louisville, KY 40292, USA
BMC Bioinformatics 2016, 17(Suppl 10):I1
The University of Tennessee (UT) and the Kentucky Biomedical
Research Infrastructure Network (KBRIN) have collaborated over the
past fifteen years to share research and educational expertise in bio-
informatics. One result is an annual regional summit for researchers,
educators and students. The Fifteenth Annual UT-KBRIN Bioinformat-
ics Summit was held at Lake Barkley State Park from April 8-10, 2016.
A total of 184 participants pre-registered, with 85 from Tennessee, 84
from Kentucky, and the remainder from various states and inter-
national locales. Among the registrants were 64 faculty, 47 staff, 46
students, and 20 postdocs. The conference program consisted of two
workshops on the UCSC Genome Browser and two days of plenary
presentations and short talks. In addition, a poster session with 57
posters was held on Saturday evening.
Friday Workshops
Robert Kuhn (University of California – Santa Cruz) opened the Sum-
mit with the workshop “UCSC Genome Browser Part I: Visualization
Tool for Genomes.” This workshop focused on a lecture and live
demonstration of the capabilities of the UCSC Genome Browser
(http://genome.ucsc.edu/) [1-3]. Dr. Kuhn talked about many of the
capabilities of the browser, including the use of pre-defined annota-
tion tracks, the creation and use of user-defined annotation tracks
and track hubs [4], connecting to the annotation tables via database
connections [5] and the ability to implement protected sessions
through the Genome Browser in a Box [6]. After a short break,
Dr. Kuhn continued with “UCSC Genome Browser Part II: Visualization
tool for genomes hands-on experience.” In this workshop, Dr. Kuhn
focused on use of the UCSC Genome Browser through a set of user-
guided exercises intended to give participants hands-on experience
with both basic and advanced features of the genome browser.
Session I
GQ Zhang (University of Kentucky) opened the scientific session on
Saturday morning with a presentation on “The role of ontologies in
clinical and translational informatics.” His talk was broken down into
three areas based on biomedical ontologies, ontologies in use, and
ontology quality assurance. In the first portion, Dr. Zhang discussed
biomedical ontologies in general, particularly in terms of the© 2016 The Author(s). Open Access This artic
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and Translational Science, including the Appalachian Translational
Research Network which consists of clinical and translational partners
across Kentucky, Tennessee, Ohio, and West Virginia. Dr. Zhang dis-
cussed some of the challenges in scaling up translational informatics
using big data from a patient perspective to create a learning health
care system. In the second portion, Dr. Zhang discussed two re-
sources, including the National Sleep Research Resource (sleepda-
ta.org) [7] and the Center for Sudep Research [8-10]. In the final
portion, Dr. Zhang discussed ontology quality assurance with a
specific example using Gene Ontology [11] fragments and SNOMED
[12, 13] data and approaches his group has taken towards develop-
ing algorithms for ontology quality assurance [14-16].
Igor Jouline (Oak Ridge National Laboratory and The University of
Tennessee – Knoxville) followed with the plenary talk “Using evolu-
tionary history for predicting functional changes in proteins.” This
presentation focused on the use of evolutionary and conserved core
elements within systems, such as signal transduction and chemotaxis
systems within bacteria, in order to predict likely functional changes
[17-21]. Dr. Jouline gave additional examples, including the structural
diversity of chemoreceptor signaling domains [22-24]. Dr. Jouline
brought home the point of how critical it is to consider the phylo-
genetic history from a sequence point of view in order to help clas-
sify disease mutations [25]. He introduced a computational approach
his group has developed which looks at evolutionary changes in
genes and their paralogs, and showed that changes need to be con-
sidered across all copies, in order to fully understand disease implica-
tions [26].
Session II
Nancy Cox (Vanderbilt University) led the second session on Saturday
morning with a presentation titled “Building a catalog of gene to
medical phenome: New ways of understanding the biological mecha-
nisms of disease.” In this presentation, Dr. Cox presented PrediXcan,
an approach to medical informatics data integration [27]. Highlighted
within this talk were preliminary results of applying PredicXcan to
Vanderbilt University’s BioVU [28] which contains several over
215,000 subjects with DNA. Within this dataset are approximately
20,000 dense GWAS genotypes and 42,000 exome chips. Dr. Cox dis-
cussed how nearly all genes have a high correlation in at least one
tissue type, with 4,000-9,000 correlating within any given tissue.
Among the research results presented were several novel gene-
phenotype relationships built upon disease models of genetically
regulated expression (GReX) [27] and genotype tissue expression
(GTEx) [29]. Dr. Cox discussed how disease from a gene expression
point of view can be explained by major axes of disease risk, in
which the healthiest individuals maintain a balance in the center of
all of the axes.
Session III
Ting Wang (Washington University in St. Louis) opened up the
final plenary session with a presentation “Epigenetics roadmap.”
Dr. Wang’s talk was broken down into several sections. The first
part of his talk focused on discussion of the Roadmap Epige-
nomics Project [30, 31] which collected a variety of epigenetic
markers, including DNA methylation, open chromatin, and histonele is distributed under the terms of the Creative Commons Attribution 4.0
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tion of his talk focused on methods of accessing the Roadmap
Epigenomics data, including tracks within the UCSC Genome
Browser [4] and the WashU Epigenome Browser [32, 33] devel-
oped within his group. In the third section, Dr. Wang discussed
project extensions, including the recent 4D Nucleosome [34] which
focuses on integration of genomic and imaging data and TaRGET pro-
ject which will focus on epigenomic changes relative to toxicants. The
fourth and final portion of the talk was dedicated to discoveries aided
by the Roadmap Epigenomics, including epigenetic annotation of gen-
etic variants associated with disease [35] and genetic regulation due to
transposable elements [36, 37].
The final plenary speaker on Sunday was Csaba Kovesdy from the
University of Tennessee Health Science Center. He presented “Model-
ing clinical trials using observational methods: How Big Data can help
us.” During the course of this presentation, Dr. Kovesdy discussed the
use of Big Data in health care from the Veterans Administration (VA) in
terms of making discovery in chronic kidney disease (CKD). Dr. Kovesdy
proposed how Big Data might be used to supplement the use of clin-
ical trials, particularly in cases when a study of interest is a subset of a
larger study. In one particular case, Dr. Kovesdy discussed using data
from large studies on hypertension to make discoveries in CKD [38-40].
In addition, he discussed strengths and weaknesses of dealing with
data from the VA patient population, and potential future opportunities
with the Million Veteran Program [41].
Poster Session
A poster session and reception was held on Saturday evening with a
total of 57 posters presented across 15 categories. The largest repre-
sented categories included high throughput sequencing, bioinfor-
matics of health and disease, systems biology and networks, and
comparative genomics. 24 of the poster abstracts are highlighted
within this supplement. Eight of the poster abstracts were selected
for short 10 minute presentations at the summit, including “Identify-
ing clusters in protein structure: Comparisons between polymorphic,
pathogenic, and somatic variation” (R. Michael Sivley, Vanderbilt Uni-
versity); “Porphyromonas gingivalis and the epithelial-to-mesenchymal
transition (EMT): Signaling networks linking infection to cancer pro-
motion” (Melissa Metzler, University of Louisville); “CC-PROMISE: Pro-
jection onto the most interesting statistical evidence (PROMISE) with
canonical correlation to integrate gene expression and methylation
data with multiple pharmacologic and clinical endpoints” (Xueyuan
Cao, St. Jude Children’s Research Hospital); “Biochemically Aware Sub-
structure Search (BASS) – An algorithm for finding biochemically rele-
vant chemical subgraphs” (Joshua Mitchell, University of Kentucky);
“Integration of microRNA-mRNA interaction networks with gene expres-
sion data to increase experimental power” (Bernie Daigle, University of
Memphis); “Side-effect term matching for computational adverse drug
predictions” (AKM Sabbir, University of Kentucky); “Lentiviral
CRISPR/cas9 vector mediated miRNA editing disrupts miRNA function”
(Junming Yue, University of Tennessee Health Science Center); and
“CSI-UTR: An algorithm for characterizing 3’ untranslated region (3’
UTR) diversity in RNA-Seq data by employing RNA cleavage site inter-
vals (CSIs)” (Ben Harrison, University of Louisville).
Future Plans
The 2017 Summit is scheduled for March 20-22 at Montgomery Bell
State Park in Tennessee. Sessions will focus more on bioinformatics
research in Kentucky and Tennessee to help forge more collaborative
efforts. Plans are to include more Tennessee and Kentucky speakers,
in terms of intermediate length (20-30 minute) presentations and
short (10 minute) presentations that complement plenary session
topics as well as integrating 1 minute flash talk opportunities for
those submitting poster abstracts.
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Background
Projection onto the most interesting statistical evidence (PROMISE) is
a general procedure to identify genomic variables that exhibit a spe-
cific biologically interesting pattern of association with multiple end-
point variables. It has been successfully applied to multiple studies
with gene expression profiling or SNP data to identify genes that are
associated with intrinsically related clinical endpoint variables in can-
cer. In the context of genetic studies in clinical trials, the clinical end-
point variables are related to one another and different forms of
genetic data (such as methylation and expression) are also related to
one another.
Materials and methods
Here, CC-PROMISE, PROMISE with canonical correlation, is proposed
to extend the PROMISE procedure to integrate DNA methylation,
gene expression and multiple pharmacologic and/or clinical variables
into one test at the gene level. First, canonical correlation analysis is
performed on the multiple probe-sets measuring DNA methylation
and gene expression in one gene. Second, the methylation and ex-
pression scores of the gene are calculated as the first canonical cor-
relates of the signals of individual methylation probes and
expression probes, respectively. Third, perform PROMISE analysis with
multiple endpoints on the methylation scores and expression scores
separately. Next, the CC-PROMISE statistic is defined as the average
of the PROMISE statistics of the methylation and expression scores.
Finally, the significance of CC-PROMISE statistics is determined by
permuting the endpoint data.
Results
We applied the CC-PROMISE procedure to the Affymetrix U133A
gene expression array and Illumina 450K methylation array data of
the multi-center AML02 clinical trial (NCT00136084). The methylation
and expression of 202 genes showed a meaningful pattern of associ-
ation with in vitro drug sensitivity, minimal residual disease, and
event-free survival (p ≤ 0.001, q ≤ 0.05). Several of the identified
genes are of known relevance to disease biology, showing that CC-
PROMISE can make meaningful discoveries by effectively integrating
expression, methylation, and clinical data.
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The detection of differentially expressed (DE) genes between two or
more biological conditions is an essential step in the search for can-
didate disease genes, drug targets, and discriminative biomarkers.
Although widely used for this task, DNA microarrays are notorious for
generating noisy data. One strategy for mitigating the effects of
noise is to assay many experimental replicates. However, as this
approach can be costly and sometimes impossible with limited re-
sources, analytical methods are needed which improve DE gene
identification at no additional cost.
Materials and methods
An important source of information for differential expression ana-
lysis comes from experiments performed on microRNAs (miRNAs).
While the transcriptional roles of miRNAs are well documented, prin-
cipled methods for incorporating miRNA datasets with traditional
gene expression assays are lacking. To this end, I developed Noisy-Or
Optimization for DifferentiaL Expression analysis (NOODLE), a novel
Bayesian network-based approach for integrating miRNA-mRNA
interaction networks with microarray data to improve DE gene iden-
tification. Given a dataset of interest, NOODLE provides an efficient
mechanism for increasing belief that an mRNA is DE if one or more
interacting miRNAs are themselves DE (and vice versa).
Results
I first apply NOODLE to synthetic datasets, achieving more accurate
DE gene identification than the popular limma method over a wide
range of network topologies and configurations. Using two publicly
available human cancer datasets, I next demonstrate how use of
NOODLE increases experimental power by as much as a factor of
four. Finally, I apply NOODLE to a recent dataset interrogating ex-
pression differences between human induced pluripotent and
embryonic stem cells. My results uncover important biological differ-
ences between these stem cell types that would be missed using
existing methods.
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Background
In silico subtractive genome hybridization is a method used to iden-
tify unique genetic sequences in a genome of interest by deleting
regions of similarity with a control genome. The program Genomic
Organismal Subtractive Hybridization (GOSH) was designed and cre-
ated to complete the subtractive step of in silico subtractive
hybridization of large eukaryotic genomes using BLASTn output. A
genome file, in the .fasta format, is effectively a word document con-
taining a long string of characters. BLASTn takes two genome files
and identifies areas of alignment characterized by significant
sequence overlap. BLASTn can only compare two genomes. In order
to identify genes found specifically in a group of organisms (i.e. the
thermally dimorphic fungi), we need to compare multiple genomes
or perform sequential subtractive steps.
Materials and methods
GOSH was designed to subtract areas of alignment from ge-
nomes using BLASTn output files. The program accesses the
alignment provided by BLASTn, identifies the nucleotides making
up the shared sequences in the genome, and replaces them with
Ns in the genome file. Through iterative subtractions, a database
containing genomic sequence shared by the thermal dimorphsBlastomyces dermatitidis, Paracoccidioides brasieliensis, and Histo-
plasma capsulatum is created which can then be aligned with the
genomes of fungi which do not exhibit thermal dimorphism (e.g.
Saccharomyces cerevisiae).
Results
GOSH successfully used the alignment data provided by BLASTn
to modify a genome sequence file by replacing nucleotides in
one genome with Ns when they aligned with another fungal
genome.
Conclusions
Initially attempts to perform in silico subtractive genome
hybridization using GOSH to perform iterative subtractions gener-
ated a database of sequence. However, further investigation
found that the file contained multiple replicates of genomic se-
quence. Currently, efforts are underway to determine whether
this is due to GOSH, to an inherent flaw in the design of the
subtractive steps, or to the numerous repeats found in the ge-
nomes of B. dermatitidis and H. capsulatum.
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Background
The purpose of this study is to trace the molecular evolution of
the Paired Box (PAX) gene that was frequently expressed in di-
verse cancers and was crucial for growth and survival of cancer
cells. The long-term goal of the study is to identify conserved do-
mains of the PAX protein in a model organism that can be suit-
able drug targets for plant based anti-cancerous pharmaceutical
compounds.
The paired-box (PAX) genes encode a family of nine well-characterized
paired-box transcription factors, with important roles in development
and disease. PAX genes are primarily expressed during embryo
development, but very frequent expression was observed in di-
verse tumor cell lines such as lymphoma, breast, ovarian, lung,
and colon cancer. A phylogenetic analysis of the PAX protein will
identify crucial molecular elements that are implicated in cancer
cell survival.
Materials and methods
In the present study the Human PAX1 protein sequence was
used as a reference to retrieve homologous sequences using PSI-
BLAST. A neighbor joining phylogenetic tree was developed using
MEGA6.
Results
The conserved domains of PAX gene were identified as HTH – Helix-
Turn-Helix that are shown to mediate responses to stress including
exposure to heavy metals, drugs, or oxygen radicals across life forms.
These could be novel targets for treatment as expression of PAX2
domain has been linked with cell survival cell migration and invasion.
The generated neighbor-joining phylogenetic tree showed that the
ancestral form of PAX traces back to the American alligator with an-
other close relative in a model organism, zebrafish. PAX homologs
were present extensively in birds with the most evolved form in the
Golden-collared Manakin.
Conclusions
The bioinformatics analysis proved crucial in identifying a model
organism for researching a plant based cancer treatment in the
form of zebrafish, which is already being used as a model organ-
ism to study cancer. Present research in our lab already estab-
lished the anti-cancerous action of plant based extracts on
diverse cancers in terms of reduced cell proliferation. The study
thus suggests an effective tool to research plant based treat-
ments of diverse cancers by identifying the crucial molecular do-
mains as targets.
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Background
Thermally dimorphic fungi such as Blastomyces dermatitidis and Histo-
plasma capsulatum have the rare, amongst fungi, ability to cause in-
vasive infections in otherwise healthy individuals. In order to better
understand what makes these fungi different from state specific
fungi, we have used two bioinformatics methods to compare
dimorphic and non-dimorphic fungal genomes.
Materials and methods
First, we compiled a list of “missing” enzymes using BLAST to search
for homologs of Saccharomyces cerevisiae proteins in B. dermatitidis
and H. capsulatum. Students searched for the components of 24 S.
cerevisiae pathways in H. capsulatum and 38 S. cerevisiae pathways in
B. dermatitidis.
Second, biological sciences and computer science students collabo-
rated to create GOSH, software designed to be used to complete in
silico subtractive genome hybridization of large fungal genomes
when combined with BLASTn. A file containing thermal dimorph-
shared genome sequences was created by performing multiple align-
ments and subtractions between the thermally dimorphic fungi of
interest. This list of sequences was use to interrogate the genome
the yeast S. cerevisiae and the genome of the mold A. fumigatus.
Results
We found 29 S. cerevisiae proteins from various different pathways
lacking a clear homolog in H. capsulatum. Similarly, we found 39
missing components when we searched for S. cerevisiae.
Preliminary results of in silico subtractive genome hybridization using
GOSH combined with BLASTn are promising. The iterative analysis
pipeline identified multiple genome sequences found in dimorphic
fungi but not one of the state-specific fungi.
Conclusions
We started two separate avenues of in silico genome comparison
to identify genomic differences between thermally dimorphic
fungi and state specific fungi. Both methods yielded results con-
firming that the dimorphic fungal genomes differ from state-
specific fungi. Efforts are currently underway to expand on and
characterize these differences.
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Background
Next Generation Sequencing has created an opportunity to genetic-
ally characterize an individual both inexpensively and comprehen-
sively. In earlier work produced in our collaboration [1], it was
demonstrated that, for animals without a reference genome, their
Next Generation Sequence data can be mapped to the reference
genome of another animal from which it has recently evolutionarilydiverged producing a wealth of data on regions which have been evo-
lutionarily conserved, and variation therein which has been tolerated.
Materials and methods
Since then, 16 different animals spanning 10 different Cetartiodactyla
species have been sequenced and mapped to the Bos taurus gen-
ome at an equivalent coverage of 10X. Here, we describe this re-
source which is publicly available and may be found at 10x WGS of
Cetartiodactyla Species Mapped to Cattle [http://www.ars.usda.gov/
Research/docs.htm?docid=25590].
Results
Analysis of these mappings identifies genomic regions in the respect-
ive species that are highly conserved relative to cattle. Within these
conserved regions, species specific alleles selected for by evolution
can be identified as well as sites that vary within the respective spe-
cies. Here we present a summary of non-bovine alleles that can be
measured across these species relative to the Bovine reference gen-
ome, and identify those which appear to be common to the species,
and those which are likely variant within the species.
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Background
The volume of data that is being generated in the hospital is very
large and this large volume is due to the continuous collection of se-
quential time series data. Clinicians are expected to examine large
volumes of data along with readily available electronic medical re-
cords of patients and identify correlations between dozens to hun-
dreds of variables based on their own clinical experience to detect
significant medical events. Here, we demonstrate a data mining ap-
proach applied on physiological data to identify symbolic patterns to
derive patient similar matrices that will allow clinicians to identify
patients with similar events and phenotypes for the purpose of pre-
dicting patient outcomes.
Materials and methods
We employed symbolic aggregate approximation (SAX) and piece-
wise aggregate approximation (PAA) techniques to convert oxygen
saturation (SpO2) to symbolic patterns (Fig. 1a). We then applied data
mining techniques called Low Rank Matrix Decomposition (LRMD) on
these symbolic patterns to produce a concept vector space in which
query vector and symbolic term-to-patient were projected. Resulting
patients with similar events for each query are determined and com-
pared with a control reference of 563 de-identified patients with
asthma or related conditions using Precision and Recall measure-
ments at various time intervals prior to outcomes (i.e., death, intub-
ation, or transfer (DIT) to Intensive Care Unit).
Results
We found that this approach identified specific common patterns of
SpO2 level among cases. For example, patterns ‘cab’, ‘bac’ and ‘acb’
exist among the patients 4, 11, 13, 15, 9, 2, 5, 7, 12, 14, 10, 3 and 6
with DIT outcomes (Fig. 1b). This results indicate their possible clin-
ical use in the future to predict impending respiratory failure.
Acknowledgements
The authors would like to thank the Children’s Foundation Research Institute
(CFRI), Le Bonheur Children’s Hospital, who supported this work.
Fig. 1 (abstract P7) a Representative SAX results for SpO2 levels;
b Clustering and Heatmap analysis of LRMD
Fig. 2 (abstract P8) (Left): Top view of the hermetically sealed
module with 2 brief snaps on the bottom. (Right): internal view
showing the custom circuit board, BTLE module and coin
cell holder.
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Background
A system for monitoring the moisture level and temperature of a dis-
posable brief will be presented. The system includes a Bluetooth
wireless transmitter that works in tandem with a smart phone/tablet
application.
Materials and methods
An inexpensive disposable moisture sensor combined with a re-
usable temperature sensor are used as the wireless sensors. The
Bluetooth Low-Energy (BTLE) transceiver is powered by a 2032
coin cell battery having a lifetime greater than 3 years. The BTLE
device collects data from the sensors and transmits the data to a
smart phone/tablet. The data can be monitored locally on a
smart phone/tablet or stored on a server to be analyzed
remotely.
Results
A working prototype developed in the Wireless and IC design
Laboratory at the University of Louisville (Fig. 2) has the following
features and demonstrated characteristics:
Features:
 BTLE transmitter module sits externally on a standard
disposable brief and is connected to the brief using snaps.
These snaps provide electrical connection to the embedded
moisture sensor.
 The BTLE equipped smart phone or tablet easily interfaces with
the internet.
 The module has a low-battery alert consisting of a beep, LED
or text message.
 The smart phone / tablet sends data to a server that is time
stamped for statistical analysis.
Performance and Characteristics:
 The module includes a built-in temperature sensor with an
accuracy of +/- 0.5 C.
 The module contains a non-replaceable coin cells that last up
to 3 years with a 10 second data sampling period.
 The module has a range of at least 50’ indoors.
 The module can monitor approximate distance from the smart
phone / tablet. The module costs approximately $15 in low
volume.P9
Side-effect term matching for computational adverse drug reaction
predictions
AKM Sabbir1, Sally R Ellingson2
1Department of Computer Science, University of Kentucky, Lexington, KY
40506, USA; 2Division of Biomedical Informatics, College of Medicine,
University of Kentucky, Lexington, KY 40536-0093, USA
Correspondence: Sally R Ellingson (sally@kcr.uky.edu) – Division of
Biomedical Informatics, College of Medicine, University of Kentucky,
Lexington, KY 40536-0093, USA
BMC Bioinformatics 2016, 17(Suppl 10):P9
Background
The establishment of polypharmacological networks, all the interac-
tions between a collection of drugs and proteins, will allow for the
exploration of drug re-purposing, side effect prediction, and the de-
velopment of more efficacious drugs, targeting multiple proteins in a
disease pathway. This project will help pave the way for the compu-
tational prediction of adverse drug reactions using a polypharmaco-
logical network built using molecular docking scores, an efficient
prediction of how and how well drugs bind to a protein. The re-
search presented here is an effort to map side-effect terms associ-
ated with a toxicity screen [1], known proteins in which drugs should
not interact, to known side-effects associated with FDA-approved
drugs [2] in order to test the accuracy of predictions.
Materials and methods
Multiple methods were tested for term matching.
1. Edit Distance determines the minimum amount of editing
required to transform a source string into a destination string.
Editing operations include insertion, deletion and substitution.
Each operation involves a cost and a minimum cost path is found.
2. Knuth-Morris-Pratt is a pattern-matching algorithm that finds
the number of times a given text pattern occurs within a text
document, which has been modified to include a cost function.
3. Sense Disambiguation using meta map takes advantage of
UMLS (Unified medical language system) metathesaurus, which
is a large multi-purpose thesaurus containing medical and
health related concepts, and builds concept networks, relating
different concepts and their synonyms.
4. Language Model takes a partially formed sentence and tries to
find the most appropriate word or words to form the full and
proper sentence. Pubmed journal abstracts and titles were
used to train the language model.
Results
Sense disambiguation appears to be the most accurate methods but
only resolved around 75% of the terms. Multi-approach methods are
being investigated to achieve the maximum number of terms
matched with a high-degree of accuracy.
Conclusion
This significant research will help alleviate the current economic burden
of developing new pharmaceuticals by innovatively utilizing massive
computational power. This research will lead to the establishment of
structures to use in virtual drug screenings that will predict side-effects
quickly and efficiently, resulting in safer clinical trials, as fewer drugs




Linear Kernel SVM 0.9565
RBF Kernel SVM 0.8950
SDSAE + Fine Tuning + Linear kernel SVM 0.9569
SDSAE + Fine Tuning + RBF kernel SVM 0.9747
BMC Bioinformatics 2016, 17(Suppl 10):297 Page 7 of 12with negative off-target effects will advance to this stage, and more af-
fordable therapies, as drugs destined for failure will be predicted earlier
in the drug discovery process. This project will address important public
health concerns by providing safer and more affordable drugs.
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Background
Transcriptomic graph density and community structure remain hall-
marks of putative biological fidelity. Yet these very graphs frequently
have numerous maximum cliques, forcing top-down, density-based
algorithms to choose a starting clique in some fashion, either ran-
domly or by some often-arbitrary tie-breaking scheme.
Materials and methods
In order to help evaluate the potential effectiveness of selection
strategies, we investigate the impacts of clique choice on cluster
ontology enrichment and robustness. We employ yeast gene co-
expression data obtained from the Gene Expression Omnibus, and
create graphs in the usual fashion, by calculating all pairwise correla-
tions and placing edges between pairs correlated at or above a se-
lected threshold. We then run the noise-resilient paraclique
algorithm to generate gene clusters.
For enrichment, we use GO p-values obtained from DAVID, and com-
pare clusters obtained by repeatedly using the maximum clique with
the highest average edge weight (correlation) to clusters obtained
using the lowest average edge weight. While the use of higher
weights has much intuitive appeal, we find that with proper thresh-
old selection this choice seems to have at most a negligible effect on
paraclique enrichment.
For robustness, we introduce a new metric defined as t/(dr),
expressed as a percentage, where t denotes the total number of (not
necessarily distinct) gene pairs appearing together across all clusters,
d represents the number of distinct pairs appearing together in at
least one cluster, and r is the number of runs. Robustness thus falls
between 0% and 100%. We find that paraclique scores are generally
80% or higher, demonstrating that it produces highly repeatable
cluster profiles regardless of the particular starting clique chosen.
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Deep neural networks are shown to learn complex relationships
in data and provide greater generalization performance in diag-
nostic informatics [1, 2]. Using deep learning techniques for
large-scale omics data can be computationally expensive, as it in-
volves learning of millions of network weights. This abstract fo-
cuses on designing efficient deep learning models that are
sufficient to perform transcriptome-based cancer classification
with minimal computational elements. This includes the use of a
two layered stacked de-noising sparse auto-encoders (SDSAE) [3]
to generate a feature representation that is 200 fold smaller than
the input representation, and then use a novel fine-tuning
method for improved classification performance.
Materials and methods
One of the main challenges in solving complex supervised ma-
chine learning problems is to come up with good features.
SDSAE in context of Deep Learning is widely used in a variety
of tasks for generation of useful feature representations. SDSAE
removes redundancies while learning compact feature represen-
tations and helps the network learn important statistical regu-
larities. The reduction in number of computational elements
was achieved by drastically reducing the feature representation
from input layer to 1st hidden layer, and a moderate reduction
from 1st to 2nd hidden layer. The fine-tuning method on the
other hand forces data i.e. feature values in the new represen-
tation to converge towards the median of the respective class
samples.
Results
The entire procedure was validated upon the two class Prostate
Tumor data [4] containing 102 samples and 10509 features. The
2 layered neural network had 10509 nodes in input layer, 100
nodes in 1st hidden layer and 49 nodes in 2nd hidden layer.
Network weights connecting the layers were initialized with
denoising sparse auto-encoders and fine-tuned. Support Vector
Machine (C-SVM) was used for classifying the data samples in
the final feature representation. Our results show that while the
network had fewer computational elements, the deep learning
model with fine-tuning method gave better performance than
support vector machines and random forests. Table 1 reports
the four-fold cross validation AUC values (Area Under ROC
Curve) of several methods.References
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Table 2 (abstract P12) Results of the three methods: MEME, Weeder
and K-means approach
Sensitivity (SN) Specificity (SP) Correlation Coefficient (CC)
MEME 0.103 0.982 0.083
Weeder 0.202 0.960 0.096
K-means approach 0.176 0.971 0.090
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Background
DNA motifs are short patterns in DNA sequence and are usually asso-
ciated with a biological function. The existing techniques for identify-
ing these motifs are either computationally prohibitive or stuck at a
local minimum. In this study, we propose a hybrid technique which
combines both profile and word-based approaches. The proposed
technique has comparable performance with classical tools such as
MEME [1] and Weeder [2].
Materials and methods
Two types of motif features were used to discriminate motifs
from background subsequences. First, relative complexity (ratio
of N-mer complexity to average of background N-mers complex-
ities) was used to capture motif structure. Second, contextual
features like a position-specific scoring matrix (PSSM)-based
score was used to isolate a motif from its background sequence.
Unlike the expectation maximization (EM) algorithm, PSSM is
computed from only one sequence. In turn, the score for each
motif is constant and can be computed independent of the clus-
tering technique.
To simplify the clustering step, features were multiplied to form one
composite feature. This will reduce feature space and consequently
increase the speed. K-means clustering technique was used to cluster
all possible N-mers into two cluster (background and candidate). To
capture over-represented candidate motifs, N-mers in candidate clus-
ter are counted and ones with high count were determined. Finally,
candidates with more than one occurrence per sequence were
removed.
To evaluate the proposed technique, benchmark proposed by
Sandve [3] was used. This benchmark includes 50 datasets from
TRANSFAC database [4]. Different performance measures were cal-
culated in nucleotide-level of both known and predicted sites [5].
Based on true positives (TP), true negatives (TN), false positives
(FP) and false negatives (FN), the correlation coefficient was
calculated:
Correlation Coefficient CCð Þ ¼ ðTP  TN − FP  FNÞﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃðTP þ FNÞðTP þ FPÞðTN þ FNÞðTN þ FPÞp
Results
Results generated from the benchmark are presented in Table 2.
These results represent the average of each performance measure
over the 50 datasets. Weeder showed the highest sensitivity
followed by our technique and MEME. Weeder has high sensitiv-
ity because it allows few mismatched in pattern search. On the
other hand, our technique searches for the exact match. It was
also interesting to see that Weeder has the highest sensitivity
with the lowest specificity. In contrast, MEME has the highest
specificity with the lowest sensitivity. In conclusion, our proposed
technique was comparable with the existing techniques and its
sensitivity can be improved with allowing mismatches in pattern
search.
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Background
Global nuclear run-on sequencing (GRO-seq) and precision nuclear run-
on sequencing (PRO-seq) are techniques for mapping and quantifying
transcriptionally engaged polymerase density genome-wide. They have
been widely used for measuring RNA polymerase pausing and elong-
ation, and condition-dependent transcription response. In addition,
they provide a sensitive way to identify and quantify enhancer-derived
RNAs (eRNAs), which is a robust indicator of enhancer activity.
Results
We developed a method to identify active enhancers from GRO/
PRO-seq data. Applied the method to human 15 cell lines, over
ten thousands of active enhancers were uncovered including 80%
novel enhancers. Aligning histone modification data to the en-
hancer centers, we found that novel enhancers were flanked by
expected histone modification markers of H3K4me1 and H3K27ac.
Moreover, the signal flanking novel enhancers was as strong as
that around known enhancers, indicating the reliability of novel
active enhancers identified from GRO/PRO-seq data. In 12 of the
15 cell lines, the transcription abundance of enhancer-linked
genes was found significantly higher than the expression of non-
linked genes. In addition, the tissue specific genes were observed
to locate remarkably closer to tissue specific enhancers than to
universal enhancers, suggesting the regulation role of tissue spe-
cific enhancers on tissue specific expression.
Conclusions
The method provides efficient analysis of GRO/PRO-seq data for
active enhancer identification. The large-scale discovery of active en-
hancers across multiple human cell lines provides valuable source for
enhancer study.
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Background
As genetic sequence data is now being used to make health care de-
cisions, analysis tools needed for personalized medicine must be well
tested and verified while establishing and maintaining competency
in the state-of-the-art in both the technology and analysis. This study
demonstrates the usefulness of high-confident call sets (validated
genomic variations) in testing and optimizing bioinformatics
pipelines.
Materials and methods
The Genome Analysis Tool Kit (GATK) [1, 2] best practices pipe-
line for genomic variation detection was used on two Illumina Hi-
Seq genomic datasets obtained from a sample originating from
NA12878, a participant in the HapMap [3, 4] project. One of the
test datasets consists of four pairs of paired end data from differ-
ent runs with an average depth of coverage of 14. The other
consists of one pair of paired end data with an average depth of
coverage of 58. Two high-confident call sets are used to detect
the accuracy of the pipeline. The National Institute for Standards
and Technology call set developed by the Genome in a Bottle
Consortium incorporates several sequencing technologies and
analysis methods [5] and the Illumina Platinum Genome call set
requires concordance across multiple analysis methods and incor-
porates an inheritance structure.
Results
In this study, several types of alternatives in the entire workflow were
evaluated.
1. Experimental conditions: one sequencing run with a higher depth
of coverage has about 1% lower true positive rate and .1% higher
positive predictive power than four runs with lower coverage each.
2. Computational architecture: threading to efficiently use a 16 CPU
node gives a speed-up of almost 4.5 times that of using only one
CPU; however, utilizing a 32 CPU node only gives a speed-up of 1.1
over that of a 16 CPU node.
3. Analysis tools: UnifiedGenotyper is about 7 times faster than Hap-
lotypeCaller which only has about a 1-2% increase in true positive
rates.
4. Comparison tools: GATK VariantEval, Useq vcfcomparator, and RTG
vcfeval all produce similar comparison results.
Conclusion
A workflow that easily and reproducibly tests the accuracy and effi-
ciency of a given method on a given computational platform is crit-
ical in order to confidently and cost-effectively utilize genomic
sequencing in a clinical setting.
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Background
While high-throughput DNA-based clinical assays are becoming in-
creasingly common, RNA-based approaches primarily remain a re-
search activity. Nonetheless, the potential for clinical benefit offered
by RNA-Seq, particularly in the field of personalized oncology, is sub-
stantial. RNA-Seq expression profiling of tumor samples may
reinforce or deconvolute the findings of DNA-based testing. This is
done by revealing the existence and magnitude of deviations from
normal levels of gene expression in the tumor’s complex molecular
landscape. Such evidence could ultimately be used to highlight and
select targeted treatment options to improve patient care. However,
multiple challenges exist to the routine implementation of these
methods. One notable obstacle, particularly related to metastatic
cancer, is the lack of normal tissue from the same site with which to
compare RNA expression levels. Other challenges include the impact
of reference sample size, reference tissue source, and the appropriate
normalization and differential expression (DE) method for the N = 1
tumor sample. These challenges must be solved in order to
categorize gene expression as normal or abnormal and therefore to
unlock the potential of RNA-Seq profiling in the personalized oncol-
ogy setting. We describe an approach taken within Mayo Clinic’s Cen-
ter for Individualized Medicine (CIM) to compile normal reference
expression ranges and thus evaluate DE in a N = 1 tumor sample.
Utilizing data generated in house and by the The Cancer Genome
Atlas (TCGA), we formulated a workflow and analytical methods that
should inform and enable other researchers working in the personal-
ized oncology field.
Results
We developed a bootstrap based confidence interval method to
identify DE genes in a N = 1 patient tumor using different references.
RLE (Relative Log Expression), 75th Quantile and RPKM (reads per kilo
base per million mapped reads) normalization methods has a min-
imal effect upon DE calling. An increase in the number of normal ref-
erence samples stabilized the number of DE calls. We observed
higher gene level variance in the TCGA reference samples in com-
parison with in-house reference samples. DE calls using a reference
from the same site were compared against mixed reference tissue
samples from bladder, breast, uterine and lung tissues. While not
ideal, if reference samples from the same tissue site are not available,
mixed tissue reference samples can be used to recover some of the
DE genes.
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Fig. 3 (abstract P16) Scaled output of Tile 1301.
Table 3 (abstract P16) Analysis of sample bleeding plausibility.
Total viral reads Number of viral reads
plausibly from bleeding
Fraction of viral reads
plausibly from bleeding
28H reads 2,692 81 3.01 %
24H reads 2,037 56 2.75 %
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Background
Coffee is a widely traded agricultural commodity across the globe.
The emerging coffee ringspot virus (CoRSV) reduces the quality of
beans harvested and amount produced by infected plants [1].
Besides coffee, CoRSV also infects Chenopodium quinoa when incu-
bated at 28° C (4° C above typical conditions for this plant) – an
expanded host range which may indicate increasing risk to crops as
global temperatures continue to rise [1]. Examining the differences in
expression levels between infected and uninfected C. quinoa may
shed light into the effect of CoRSV on gene expression and the effect
of temperature on host susceptibility.
Material and methods
As an initial stage toward this goal, we developed methods for pro-
cessing RNA-Seq data of virus-infected plants for which there is no
reference genome. Our methods began with paired-end Illumina
RNA-Seq data from three samples of Chenopodium quinoa: one sam-
ple infected with CoRSV and incubated at 28° C (28V), another sam-
ple uninfected and incubated at 28° C (28H), and the third
uninfected and incubated at 24° C (24H). First, we analyzed the qual-
ity of the RNA-Seq data with fastqc [2], and trimmed low quality
reads with Trimmomatic-0.30 [3]. We then aligned the trimmed reads
to the viral RNA genome (GenBank accession numbers KF812525.1
and KF812526.1) [1] using Bowtie 2 [4]. We used HTSeq-count [5] to de-
termine the number of reads that mapped to each viral gene. Reads
from the uninfected samples which mapped to viral genes were exam-
ined for the possibility of artifacts arising from sample bleeding. To
assist with this examination, we wrote a Python program to visualize
the layout of reads as they were arranged on the Illumina flow cell.
Finally, we are in the process of building a de novo transcriptome
assembly of the non-viral reads using trinityrnaseq-2.1.1 [6].
Results
The results of processing the data with the Python program indicate
that the three data sets were well dispersed across the flow cell.
Pixels in the image are colored based on the percent composition of
each data set in a particular area of the flow cell (Fig. 3). Gray areas
indicate an even proportion of reads from each data set. Additionally,
for each read that mapped to the viral genome from the healthy
plants (28H and 24H), the identity of the nearest neighbor on the
flow cell was determined. Only 3.01% of 28H reads and 2.75% of 24H
reads had viral reads from the virus-infected plant as their nearest
neighbors (Table 3). Thus, sample bleeding during sequencing can-
not explain the vast majority of viral reads obtained from the healthy
plants. Alternative hypotheses must be investigated to account for
these results.
Top image: Tile 1301 at scale 100. Bottom image: red-outlined sec-
tion from Tile 1301 at scale 1. Red pixels represent 28V reads, green
pixels 28H reads, blue pixels 24H reads, and black pixels represent
viral reads from any of the three samples.
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Background
Acinetobacter baumanii is an important nosocomial pathogen in the
US and worldwide. It is of great concern because it rapidly acquires
antibiotic resistance (multi-drug resistant A. baumanii or MDRAB) and
is resistant to all antibiotics, except the polymixins, in many medical
centers. The time to effective antibiotic therapy correlates with pa-
tient survival, thus the initial antibiotic selection is critical. Transcrip-
tomic biomarkers of resistance could lead to more rapid diagnosis
and treatment for MDRAB infections.
Materials and methods
Three MDRAB clinical isolates were selected for RNAseq analysis
based on varying drug resistance phenotypes (Table 4). They
were cultured, in duplicate, in LB broth, and RNA was isolated
using the Qiagen RNeasy kit. Illumina Genome Analyzer 2 (GAIIx)
sequencing was performed using 49 bp single end reads at CO-
FACTOR Genomics (St. Louis, MO). Assembly to reference genome
(A. baumannii ATCC 17978) was done using CLC Genomics Work-
bench version 8.5.1. Transcripts mapping to genes with positive
RPKM values were classified as present and a VENN overlap dia-
gram was constructed using VENNY 2.0. Annotations were down-
loaded from NCBI.
BMC Bioinformatics 2016, 17(Suppl 10):297 Page 11 of 12Results
There were 27 – 35 million transcript read mappings to the ref-
erence genome for each of the two replicate runs per isolate.
Numbers of unique and overlapping transcripts are presented in
Fig. 4. Annotation of unique transcripts identified genes associ-
ated with aminoglycoside and other types of antibiotic and
stress resistance, as well as virulence. As an example, only iso-
late 13 expresses the acetyltransferase that confers resistance to
aminoglycosides, and isolate 13 is resistant to all tested
aminoglycosides.
Conclusions
Transcriptomic analysis of three MDRAB isolates identified tran-
scripts for genes associated with specific antibiotic resistance
mechanisms. Acetyltransferase is known to confer aminoglycoside
resistance in A. baumanii, thus its expression could be used as a
biomarker in the rapid identification of aminoglycoside resistance
in A. baumanii. These transcripts could be used as biomarkers for
resistance and rapidly identified by PCR, decreasing the time re-
quired to begin effective antibiotic therapy.Acknowledgements
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24S1 and G12 MD007586.Fig. 4 (abstract P17) RNA-Seq Transcript overlap of three MDRAB c
linical isolates shows 91% common and 0.7 – 1.2% unique
transcripts among the isolates.
Table 4 (abstract P17) Antibiotic resistance profiles of A. baumannii
clinical isolates obtained from Nashville General Hospital at Meharry.
(R = Resistant, S = Susceptible, I = intermediate). Antibiotics are:
AK (Amikacin), GM (Gentamycin), TO (Tobramycin), A/S (Ampicillin/
Sulbactam), ETP (Ertapenem), MER (Meropenem), CAX (Ceftriaxone),
CAZ (Ceftazidime), CFT (Cefitaxime), CPE (Cefepime), CP (Ciprofloxacin),
LVX (Levofloxacin), T/S (Trimethoprim/Sulfamethoxazole), PI (Piperacillin),
TIM (Ticaricillin/K Clavulanate), TE (Tetracycline).P18
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Background
In a genome sequencing project, contaminating DNA from non-
target organisms can result in errors in downstream analyses. These
non-target organisms may include pathogens or parasites present in
the original sample, as well as contaminants introduced in the se-
quencing process. As a genome assembly algorithm cannot distin-
guish between target and contaminant DNA, sequence reads from
contaminants can and will be assembled into contigs. To prepare the
new equine reference genome (EquCab3) for publication, contamin-
ant contigs must be identified and screened out.
Identification of sequences as contaminants requires a metagenomic ap-
proach. Many software packages can be used to identify sequences
taxonomically in metagenomics studies, but they often require very long
run times and can result in many false positives. Kraken [1] addresses
both of these problems by using exact matches to k-mers, rather than
similarity, to identify sequences. Although Kraken was not designed spe-
cifically to identify contaminants in a eukaryotic genome assembly, it
has been shown to be effective for screening the bovine genome [2]. In
the current study we similarly use and test Kraken to screen EquCab3.
Materials and methods
To build the Kraken database, we downloaded all bacterial and viral ge-
nomes from NCBI RefSeq (11,061 genomes total) and used a k-mer
length of 31. We used Kraken to search EquCab3 contigs (n = 106,319).
For each flagged contig, we calculated the number of k-mer hits per
kilobase of contig length. Then, we downloaded all nonredundant bac-
terial proteins from RefSeq to build a BLAST database (46,173,990 pro-
teins total). We queried this database for Kraken-flagged contigs with >1
k-mer hit per kilobase using BLASTX. Contig hits with >90% sequence
identity with a bacterial protein sequence along >50% of its length
were considered significant. Finally, we mapped 30X Illumina HiSeq 2 ×
100bp genomic DNA reads from three other horses (Thoroughbreds
TB03 and TB10, Standardbred ST22) to EquCab3 using BWA MEM [3],
and we calculated mapping coverage for each Kraken-flagged contig.
Reads with mapping quality <10 were excluded from the calculation.
Results
Out of the 106,319 total EquCab3 contigs, 7,565 were identified as
possible contaminants based on k-mer matches. Of the Kraken-
flagged contigs, 2,257 matched more than 1 hit per kilobase, and
697 of these contained significant BLAST hits to bacterial proteins.
When the short reads from three horses were mapped to these Equ-
Cab3 bacterial contigs, 217 contigs had very low (<5%) mapping
coverage, indicating that the sequence was not found in the other
horses. In addition, 31 bacterial contigs were mapped with >80%
coverage from one or more of the test horses.
Conclusion
The 217 contigs in EquCab3 containing significant BLAST hits to bacter-
ial proteins, as well as very few mapped short reads from equine gen-
omic DNA, are likely to be contaminants. These contigs are all under 3
kb in length. Thirty-one contigs with significant BLAST hits to bacterial
proteins are also well-mapped with equine short reads, suggesting that
some contamination may be present in the three equine samples. Al-
ternatively, some of these “shared contaminants” may be misidentified
equine DNA, which warrants further investigation. Taxonomically, most
of the contaminant sequences can be identified as commensals, includ-
ing Escherichia coli, Campylobacter jejuni, and Enterobacter spp., which
are known to inhabit the mammalian digestive tract. These bacteria
could be introduced during sampling or any other step involving a hu-
man or horse.
Fig. 5 (abstract P20) Overall infrastructure for BIG initiative.
BMC Bioinformatics 2016, 17(Suppl 10):297 Page 12 of 12Because so few Kraken-flagged contigs were confirmed as bacteria
with BLAST, we conclude that Kraken alone was not sufficient to
accurately identify contigs as bacteria. The screening results of meta-
genomics tools such as Kraken need to be further corroborated using
other independent analytical methods.
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Background
The present study traces the molecular evolution of specific can-
cer driver genes selected from a list of 125 genes identified by
the cancer genome landscapes study [1]. The purpose of the
study is to identify ancestral forms of the cancer driver genes
and identify the specific conserved domains during the molecu-
lar evolution in terms of gene duplications and mutational
changes.
Materials and methods
The randomly chosen genes chosen in the specific study were ABL1,
BRACA1, CASP8, DAXX, EZH2, FOXL2, GATA1, HRAS, IDH1, JAK1,
MAP2K1, NOTCH1 and TP53. Protein sequences retrieved from the
NCBI database by the PSI-BLAST program were subjected to multiple
alignment and neighbor joining phylogenetic trees were constructed
using the MEGA6 program [2].
Results
Comprehensive bioinformatics analysis of the resulting multiple
alignments and the generated phylogenetic trees gathered valu-
able insights in identifying the specific molecular elements that
form the basis of the specific cancer types, the related molecular
processes affected across diverse life forms during the molecular
evolution of the genes and suggest specific molecular targets for
cancer treatment.
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Background
Healthcare organizations are increasingly moving towards personalized
medicine and integrating genomic information into day to day clinicaldecision making [1]. Biorepositories help facilitate this movement by
providing the means to store, link, and analyze biological samples, clin-
ical information, and large-scale data sets, essentially creating a plat-
form through which clinicians and researchers in biomedical and
pharmaceutical industries can identify genetic variants and mutations
that cause or are associated with disease symptomology, susceptibility
and/or prognosis, variation in drug and therapeutic responses, and new
disease subtypes. Such information is necessary for the development
and evaluation of new targeted drugs and treatment modalities, new
biomarkers or more accurate diagnostic tests, proper clinical trial de-
sign, and informed life decisions by patients and their families. Effective
biorepository development and operation, particularly in a hospital set-
ting, is a complex task requiring a cohesive effort from multiple groups
and technologies within the organization. At the heart of this process is
a laboratory information management system (LIMS) that supports a
workflow dependent upon real-time patient consenting and integration
of patient data from the Electronic Medical Record (EMR), accurate and
efficient sample collection, processing, storage, and distribution, and re-
liable integration of analysis data. The LIMS must be customizable to fit
a laboratories’ equipment and procedures while still effectively protect-
ing personal health information.
Materials and methods
In order to facilitate functionality tailored to biorepository needs we
have built an agile and streamlined LIMS infrastructure that is cost ef-
fective, provides improved flexibility for high-throughput laboratory
workflow, and has a modular design to facilitate modification and in-
stallation of new equipment and data systems (Fig. 5). The BLIMS has
two major components: EMR interfaces and a template driven LIMS
application. EMR interfaces were developed using open source Mirth
Connect interface software using HL7 [2]. The LIMS system was de-
veloped with an interface built using PHP, JQuery & Bootstrap for
flexibility and responsiveness, MVC (Model View Controller) paradigm
is used to abstract various functional components of the system for
extendibility, security and understandability. MySQL with PDO (PHP
Data Objects) is used for data storage and manipulation. Server side
functionality provides features like customizable sample templates,
batch mode sample collection, and support for data import from cus-
tom laboratory equipment, multiform import in XML, CSV or TXT
formats. QA/QC, tracking equipment, sample locations, statuses, and
strong security with grid based access control and completed audit
log management.
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